Planta Med 2002; 68(12): 1140-1141
DOI: 10.1055/s-2002-36347
Letter
© Georg Thieme Verlag Stuttgart · New York

Two Flavonols from Artemisa annua which Potentiate the Activity of Berberine and Norfloxacin Against a Resistant Strain of Staphylococcus aureus

Frank R. Stermitz1 , Lacey N. Scriven1 , George Tegos2 , Kim Lewis2
  • 1Department of Chemistry, Colorado State University, Fort Collins, Colorado, USA
  • 2Department of Biology, Northeastern University, Boston, Massachusetts, USA
Further Information

Publication History

Received: April 8, 2002

Accepted: July 28, 2002

Publication Date:
20 December 2002 (online)

Preview

Abstract

Bioassay-guided fractionation of an extract of Artemisia annua L. (Asteraceae) was conducted in order to assess the possible presence in the plant material of inhibitors of bacterial multidrug resistance pumps. Fractions were tested for Staphylococcus aureus growth inhibition in the presence of a subinhibitory dose of the weak antibacterial alkaloid berberine. Active fractions yielded the flavones chrysosplenol-D and chrysoplenetin, which themselves had very weak growth inhibitory action, but which made a potent combination with berberine. In comparison with work on other flavonols, it is likely that potentiation is due to the inhibition of an S. aureus multidrug resistance (MDR) pump. These same two flavonols were earlier reported to potentiate the activity of artemisinin against Plasmodium falciparum.

References

Prof. Frank R. Stermitz

Department of Chemistry

Colorado State University

Fort Collins, Colorado 80523-1872

U.S.A.

Email: frslab@lamar.colostate.edu

Fax: +1 970-491-5158